Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04138875
Title A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)
Recruitment Withdrawn
Gender
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

lymphoma

Therapies

Bendamustine + Brentuximab vedotin + Rituximab

Brentuximab vedotin + Rituximab

Age Groups:
Covered Countries USA

Facility Status City State Zip Country Details
Yale University New Haven Connecticut 06519 United States Details
Mayo Clinic Rochester Minnesota 55902 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field